Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2003

View Archived Issues

Spotlight on F-13640, a 5-HT1A receptor agonist for the treatment of neuropathic pain

NW-1029 inhibits Na+ currents in rat sensory neurons

NO-releasing paracetamol derivative NCX-701 reduces pain-related behavior in nerve-injured rats

Antihyperalgesic effects of cizolirtine in diabetic rats via adenosine A1 and CCK2 receptors

PJ-34, a PARP inhibitor, reverses early diabetic neuropathy in rats

New antitumor, antibacterial and antifungal agents from Penicillium sp.

Pfizer presents novel PDE4 inhibitors and their use

Novel cathepsin K inhibitors under study at Aventis

Neurocrine patent covers series of pyrrole-based melanocortin receptor modulators

KCNQ potassium channel openers identified by ICAgen researchers

GSK patent describes new vanilloid VR1 antagonists, their preparation and use

Serostim E.U. appeal results in second negative opinion

Incyte and Pharmasset enter Reverset licensing agreement

New phase II trial evaluates MDX-010 for metastatic breast cancer

Second phase III trial of SPI-0211 for constipation completes enrollment

Taisho ends anti-CD23 collaboration

Long-term phase I/II data support use of I2S for Hunter's syndrome

Teva submits rasagiline NDA for Parkinson's disease

Completion of phase I Aurexis study

SBIR grant supports StemCells' spinal cord injury work

New siRNA agents demonstrate inhibition of SARS virus

Pregabalin safe and effective in postherpetic neuralgia and fibromyalgia syndrome

Everolimus alleviates cardiac vasculopathy after heart transplant

Discovery and SAR of a series of sulfonamides as JNK inhibitors reported by Serono

J&J presents new series of histamine H3 antagonists with biological activity

Boehringer Ingelheim presents data on new HCV NS5B RNA-dependent RNA polymerase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...